Levetiracetam Tablet, Film Coated
Product Images NDC 63629-4137

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 63629-4137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 01

A formula chart displaying the calculation for total daily dose in milliliters per day based on daily dose in mg per kg per day multiplied by patient weight in kilograms, divided by 100 mg per mL concentration.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 02

This image shows a text panel detailing the formula for calculating creatinine clearance (CLcr). It includes the equation incorporating age, weight, serum creatinine, and an adjustment factor for female patients, followed by an adjustment for body surface area (BSA). The calculations are presented as formulas with variables and units.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 03

Chemical structure of levetiracetam, showing its molecular arrangement including a pyrrolidone ring and side chains consistent with the active ingredient levetiracetam.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 04

A bar graph comparing the percentage of patients among three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The y-axis represents the percentage of patients, showing 7.4% for Placebo, 37.1% for Levetiracetam 1000 mg/day, and 39.6% for Levetiracetam 3000 mg/day. Each bar is labeled with the number of patients (N) in each group.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 05

A bar chart comparing the percentage of patients across three groups: Placebo (111 patients), Levetiracetam 1000 mg/day (106 patients), and Levetiracetam 2000 mg/day. The chart shows increasing percentages from placebo to higher doses, with values approximately 6.3%, 20.8%, and 35.2%, respectively.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 06

Bar chart comparing the percentage of patients between a placebo group (N=104) and a Levetiracetam group (3000 mg/day, N=180). The placebo group shows 14.4%, while the Levetiracetam group shows 39.4%, with an asterisk indicating statistical significance or notable difference.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 07

A bar chart comparing the percentage of patients in two groups: Placebo (N=97) and Levetiracetam (N=101). The y-axis represents the percentage of patients, with the Placebo group showing 19.6% and the Levetiracetam group showing 44.6%. The chart highlights the difference in patient percentages between the two groups.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 08

Bar chart comparing the percentage of patients for placebo (19.6%) and Levetiracetam (43.1%) groups in a clinical study. The x-axis shows the groups with sample sizes (Placebo N=51, Levetiracetam N=58) and the y-axis shows percentage of patients from 0% to 45%. An asterisk marks the Levetiracetam bar to indicate significance or special note.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 09

A bar chart comparing the percentage of patients between two groups: Placebo (N=84) and Levetiracetam (N=79). The y-axis represents the percentage of patients from 0% to 100%. The Placebo group shows 45.2%, and the Levetiracetam group shows 72.2%, with an asterisk above the Levetiracetam bar indicating statistical significance or emphasis.*

FDA Label Image

Label Image (Lbl636294137)

Label for Levetiracetam 500 mg tablet, film coated, provided by Bryant Ranch Prepack. The label compares this generic tablet to Keppra 500 mg by Lupin Pharmaceuticals, Inc. It includes storage instructions to keep at 20°-25°C and to keep drugs out of reach of children. The NDC highlighted is 63629-4137, and the label indicates a quantity of 90 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.